Statistical Learning Models for Therapeutic Cell Composition Prediction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for characterizing effective therapeutic cell compositions, particularly those expressing recombinant receptors like CARs, lack efficiency in predicting attributes that ensure optimal clinical response and manufacturing processes, leading to variability in treatment outcomes.
Innovation Solution
The use of statistical learning models, such as canonical correlation analysis and lasso regression, to predict the attributes of therapeutic cell compositions based on input composition attributes, allowing for the selection of appropriate manufacturing processes to achieve desired cell phenotypes and activities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current characterization methods are used for therapeutic cell compositions, then manufacturing and treatment processes can be completed, but prediction efficiency of attributes ensuring optimal clinical response is insufficient leading to variability in treatment outcomes
Solution Approach 1:
The patent applies preliminary action by performing statistical learning analysis on input cell composition attributes before manufacturing to predict therapeutic cell composition attributes. This pre-manufacturing prediction allows selection of optimal manufacturing processes and treatment regimens in advance, improving both prediction efficiency and treatment outcome consistency by identifying promising cell compositions before resource-intensive manufacturing occurs.
2Measurement precision
If comprehensive characterization of therapeutic cell compositions is performed, then accurate prediction of clinical response can be achieved, but manufacturing complexity and time increase
Solution Approach 1:
The patent performs statistical learning analysis on input composition attributes before manufacturing to predict therapeutic cell composition attributes, eliminating the need for extensive post-manufacturing characterization. This preliminary prediction approach maintains accurate clinical response prediction while significantly reducing manufacturing time by avoiding iterative testing and characterization cycles.
Solution Approach 2:
The patent creates a statistical model (canonical correlation analysis or lasso regression) that copies the relationship between input composition attributes and therapeutic cell composition attributes. This model serves as a virtual replica that can predict outcomes without requiring physical manufacturing and testing of multiple cell composition variants, thereby maintaining prediction accuracy while reducing time and resource requirements.
3Productivity
If statistical learning models are used to predict therapeutic cell composition attributes, then manufacturing processes can be optimized, but process complexity increases
Solution Approach 1:
The patent transforms complex manufacturing optimization into a statistical parameter analysis problem. By changing the approach from physical manufacturing trials to statistical learning on composition parameters, the system efficiently predicts therapeutic cell composition attributes and selects optimal manufacturing processes. The complexity is managed through standardized statistical methods (canonical correlation analysis or lasso regression) that can be implemented with routine computational resources.
Data Source
AI summary
Provided are methods for determining or predicting attributes of therapeutic cell compositions in connection with cell therapy. The cells of the therapeutic cell composition express recombinant receptors such as chimeric receptors, e.g. chimeric antigen receptors (CARs) or other transgenic receptors such as T cell receptors (TCRs). The methods provide for the identification of correlations between input composition (e.g., starting material derived from subjects for producing a cell therapy) attributes and therapeutic cell composition attributes.